Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
150
Views
93
CrossRef citations to date
0
Altmetric
Research Article

Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum

, , , &
Pages 609-617 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Yan Li, Jezrael L. Revalde, Glen Reid & James W. Paxton. (2010) Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews 42:4, pages 590-611.
Read now
Anne F. Alex, Manfred Spitznas, André P. Tittel, Christian Kurts & Nicole Eter. (2010) Inhibitory Effect of Epigallocatechin Gallate (EGCG), Resveratrol, and Curcumin on Proliferation of Human Retinal Pigment Epithelial Cells In Vitro. Current Eye Research 35:11, pages 1021-1033.
Read now
ThomasE. Kraft, Daniel Parisotto, Christina Schempp & Thomas Efferth. (2009) Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol. Critical Reviews in Food Science and Nutrition 49:9, pages 782-799.
Read now
Alan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, Margherita Strolin Benedetti, Pascal Demoly & Keith Tipton. (2009) Drug interactions. Drug Metabolism Reviews 41:3, pages 486-527.
Read now
Rainer Cermak. (2008) Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 4:1, pages 17-35.
Read now
M. Miksits, A. Maier-Salamon, S. Aust, T. Thalhammer, G. Reznicek, O. Kunert, E. Haslinger, T. Szekeres & W. Jaeger. (2005) Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35:12, pages 1101-1119.
Read now
C. De Santi, A. Pietrabissa, F. Mosca, A. Rane & G. M. Pacifici. (2002) Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:5, pages 363-368.
Read now
F. Marchetti, C. De Santi, M. Vietri, A. Pietrabissa, R. Spisni, F. Mosca & G. M. Pacifici. (2001) Differential inhibition of human liver and duodenum sulphotransferase activities by quercetin, a flavonoid present in vegetables, fruit and wine. Xenobiotica 31:12, pages 841-847.
Read now
C. De Santi, A. Pietrabissa, R. Spisni, F. Mosca & G. M. Pacifici. (2000) Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30:9, pages 857-866.
Read now
C. De Santi, A. Pietrabissa, F. Mosca & G. M. Pacifici. (2000) Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30:11, pages 1047-1054.
Read now

Articles from other publishers (82)

Meng-Qin Pei, Li-Ming Xu, Yu-Shen Yang, Wei-Can Chen, Xin-Li Chen, Yu-Ming Fang, Shu Lin & He-Fan He. (2024) Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders. Brain Research 1830, pages 148821.
Crossref
Matheus de Freitas Silva, Flávia Pereira Dias Viegas, Vanessa Silva Gontijo, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damásio, Gabriel Pinto da Silva Fonseca, Isabela Marie Fernandes Silva, Larissa Emika Massuda, Maria Fernanda da Silva, Thâmara Gaspar Campos Thâmara Gaspar Campos, Priscila da Mota Braga & Claudio Viegas. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 1 157 .
Ming‐yang Liu, Liang Zhang, Wei‐dong Zang, Kai‐guang Zhang, Hai‐jun Li & Yan‐zheng Gao. (2022) Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review. Orthopaedic Surgery 14:12, pages 3141-3149.
Crossref
Ekta Yadav, Pankajkumar Yadav, Mohd Masih Uzzaman Khan, HariOm Singh & Amita Verma. (2022) Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction. Frontiers in Pharmacology 13.
Crossref
Flávia P. Dias Viegas, Vanessa Silva Gontijo, Matheus de Freitas Silva, Cindy Juliet Cristancho Ortiz, Graziella dos Reis Rosa Franco, Januário Tomás Ernesto, Caio Miranda Damasio, Isabela Marie Fernandes Silva, Thâmara Gaspar Campos & Claudio Viegas. (2022) Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents. Current Neuropharmacology 20:7, pages 1297-1328.
Crossref
Zonish Saleem, Kanwal Rehman & Muhammad Sajid Hamid Akash. (2022) Role of Drug Delivery System in Improving the Bioavailability of Resveratrol. Current Pharmaceutical Design 28:20, pages 1632-1642.
Crossref
Vivek P. Chavda, Aayushi B. Patel, Kavya J. Mistry, Suresh F. Suthar, Zhuo-Xun Wu, Zhe-Sheng Chen & Kaijian Hou. (2022) Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges. Frontiers in Oncology 12.
Crossref
Rokeya Akter, Md. Habibur Rahman, Deepak Kaushik, Vineet Mittal, Diana Uivarosan, Aurelia Cristina Nechifor, Tapan Behl, Chenmala Karthika, Manuela Stoicescu, Mihai Alexandru Munteanu, Cristiana Bustea & Simona Bungau. (2021) Chemo-Preventive Action of Resveratrol: Suppression of p53—A Molecular Targeting Approach. Molecules 26:17, pages 5325.
Crossref
Emanuela Testai, Camille Bechaux, Franca M. Buratti, Keyvin Darney, Emma Di Consiglio, Emma E.J. Kasteel, Nynke I. Kramer, Leonie S. Lautz, Nicoletta Santori, Zoi‐Vasiliki Skaperda, Dimitrios Kouretas, Laura Turco & Susanna Vichi. (2021) Modelling human variability in toxicokinetic and toxicodynamic processes using Bayesian meta‐analysis, physiologically‐based modelling and in vitro systems. EFSA Supporting Publications 18:4.
Crossref
Rajat Sandhir, Nitin Singhal & Priyanka Garg. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics 349 384 .
Catia Contado, Laura Caselotto, Paola Mello, Annalisa Maietti, Lorenza Marvelli, Nicola Marchetti & Alessandro Dalpiaz. (2020) Design and formulation of Eudragit-coated zein/pectin nanoparticles for the colon delivery of resveratrol. European Food Research and Technology 246:12, pages 2427-2441.
Crossref
Hong Huang, Ruonan Liu & Wenhua Ou. (2020) A Mini Review on the Chemical Synthesis of Resveratrol. Mini-Reviews in Organic Chemistry 17:5, pages 546-558.
Crossref
Milad Ashrafizadeh, Masoud Najafi, Sima Orouei, Amirhossein Zabolian, Hossein Saleki, Negar Azami, Negin Sharifi, Kiavash Hushmandi, Ali Zarrabi & Kwang Seok Ahn. (2020) Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines 8:8, pages 261.
Crossref
Li-Yan Wang, Shan Zhao, Guo-Jun Lv, Xiao-Jun Ma & Jian-Bin Zhang. (2020) Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer. World Journal of Clinical Cases 8:12, pages 2425-2437.
Crossref
Palak S. Phansalkar, Zhenxian Zhang, Svetlana Verenich & Phillip M. Gerk. 2020. Natural Products for Cancer Chemoprevention. Natural Products for Cancer Chemoprevention 109 141 .
Xiang-tao Huang, Xi Li, Ming-ling Xie, Zhen Huang, Yong-xiu Huang, Gui-xian Wu, Zhi-rong Peng, Yan-ni Sun, Qian-liang Ming, Yan-xia Liu, Jie-ping Chen & Shuang-nian Xu. (2019) Resveratrol: Review on its discovery, anti-leukemia effects and pharmacokinetics. Chemico-Biological Interactions 306, pages 29-38.
Crossref
Fahimeh Haghighatdoost & Mitra Hariri. (2018) Can resveratrol supplement change inflammatory mediators? A systematic review and meta-analysis on randomized clinical trials. European Journal of Clinical Nutrition 73:3, pages 345-355.
Crossref
Tomáš Řezanka, Irena Kolouchová, Lucia Gharwalová & Karel Sigler. 2018. 1 30 .
Donatella Perrone, Maria Pia Fuggetta, Fatima Ardito, Andrea Cottarelli, Anna De Filippis, Giampietro Ravagnan, Salvatore De Maria & Lorenzo Lo Muzio. (2017) Resveratrol (3,5,4′-trihydroxystilbene) and its properties in oral diseases. Experimental and Therapeutic Medicine 14:1, pages 3-9.
Crossref
Yan Li, Jezrael Revalde & James W. Paxton. (2017) The effects of dietary and herbal phytochemicals on drug transporters. Advanced Drug Delivery Reviews 116, pages 45-62.
Crossref
Danielly Ferraz da Costa, Eliane Fialho & Jerson Silva. (2017) Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target. Molecules 22:6, pages 1014.
Crossref
Ganesh Goutham, Ramar Manikandan, Manikandan Beulaja, Raman Thiagarajan, Chinnasamy Arulvasu, Munusamy Arumugam, William N. Setzer, Maria Daglia, Seyed Fazel Nabavi & Seyed Mohammad Nabavi. (2017) A focus on resveratrol and ocular problems, especially cataract: From chemistry to medical uses and clinical relevance. Biomedicine & Pharmacotherapy 86, pages 232-241.
Crossref
Shuaishuai Wang, Zheng Wang, Shuo Yang, Tiemei Yin, Yaoli Zhang, Yuanjun Qin, Robert N. Weinreb & Xufang Sun. (2017) Tissue Distribution of trans -Resveratrol and Its Metabolites after Oral Administration in Human Eyes . Journal of Ophthalmology 2017, pages 1-12.
Crossref
Mahalingam Rajamanickam Vijayakumar, Ramoji Kosuru, Parameswara Rao Vuddanda, Sanjay Kumar Singh & Sanjay Singh. (2016) Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting. Journal of Drug Delivery Science and Technology 33, pages 125-135.
Crossref
Marcos Roberto de Oliveira, Seyed Fazel Nabavi, Azadeh Manayi, Maria Daglia, Zohreh Hajheydari & Seyed Mohammad Nabavi. (2016) Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:4, pages 727-745.
Crossref
Amirhossein Sahebkar, Corina Serban, Sorin Ursoniu, Nathan D. Wong, Paul Muntner, Ian M. Graham, Dimitri P. Mikhailidis, Manfredi Rizzo, Jacek Rysz, Laurence S. Sperling, Gregory Y.H. Lip & Maciej Banach. (2015) Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology 189, pages 47-55.
Crossref
Ian Cook, Ting Wang, Charles N. Falany & Thomas S. Leyh. (2015) The Allosteric Binding Sites of Sulfotransferase 1A1. Drug Metabolism and Disposition 43:3, pages 418-423.
Crossref
Aida Zulueta. (2015) Resveratrol: A potential challenger against gastric cancer. World Journal of Gastroenterology 21:37, pages 10636.
Crossref
Valentina Ponzo, Laura Soldati & Simona Bo. (2014) Resveratrol: a supplementation for men or for mice?. Journal of Translational Medicine 12:1.
Crossref
Scott J. Brantley, Aneesh A. Argikar, Yvonne S. Lin, Swati Nagar & Mary F. Paine. (2014) Herb–Drug Interactions: Challenges and Opportunities for Improved Predictions. Drug Metabolism and Disposition 42:3, pages 301-317.
Crossref
Hiroko Tani, Susumu Hikami, Sanae Iizuna, Maiko Yoshimatsu, Takashi Asama, Hidetaka Ota, Yuka Kimura, Tomoki Tatefuji, Ken Hashimoto & Kazutaka Higaki. (2014) Pharmacokinetics and Safety of Resveratrol Derivatives in Humans after Oral Administration of Melinjo ( Gnetum gnemon L.) Seed Extract Powder . Journal of Agricultural and Food Chemistry 62:8, pages 1999-2007.
Crossref
Frédéric Mazué, Dominique Delmas, Genoveva Murillo, Diana Saleiro, Emeric Limagne & Norbert Latruffe. (2014) Differential protective effects of red wine polyphenol extracts (RWEs) on colon carcinogenesis. Food & Function 5:4, pages 663.
Crossref
Margaret O. James. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism 187 201 .
Adele Chimento, Marina Sala, Isabel M. Gomez-Monterrey, Simona Musella, Alessia Bertamino, Anna Caruso, Maria Stefania Sinicropi, Rosa Sirianni, Francesco Puoci, Ortensia Ilaria Parisi, Carmela Campana, Emilia Martire, Ettore Novellino, Carmela Saturnino, Pietro Campiglia & Vincenzo Pezzi. (2013) Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. Bioorganic & Medicinal Chemistry Letters 23:23, pages 6401-6405.
Crossref
Marina Sala, Adele Chimento, Carmela Saturnino, Isabel M. Gomez-Monterrey, Simona Musella, Alessia Bertamino, Ciro Milite, Maria Stefania Sinicropi, Anna Caruso, Rosa Sirianni, Paolo Tortorella, Ettore Novellino, Pietro Campiglia & Vincenzo Pezzi. (2013) Synthesis and cytotoxic activity evaluation of 2,3-thiazolidin-4-one derivatives on human breast cancer cell lines. Bioorganic & Medicinal Chemistry Letters 23:17, pages 4990-4995.
Crossref
Roberta Schmatz, Thaís R. Mann, Roselia Spanevello, Michel M. Machado, Daniela Zanini, Victor C. Pimentel, Naiara Stefanello, Caroline C. Martins, Andréia M. Cardoso, Margarete Bagatini, Jessié Gutierres, Claudio A. M. Leal, Luciane B. Pereira, Cinthia Mazzanti, Maria R. Schetinger & Vera M. Morsch. (2012) Moderate Red Wine and Grape Juice Consumption Modulates the Hydrolysis of the Adenine Nucleotides and Decreases Platelet Aggregation in Streptozotocin-Induced Diabetic Rats. Cell Biochemistry and Biophysics 65:2, pages 129-143.
Crossref
Maria Isabel Fernández-Marín, Raúl F. Guerrero, Belén Puertas, María Carmen García-Parrilla & Emma Cantos-Villar. 2013. Natural Products. Natural Products 2581 2615 .
Shiuan-Pey Lin, Pei-Ming Chu, Shang-Yuan Tsai, Meng-Hao Wu & Yu-Chi Hou. (2012) Pharmacokinetics and tissue distribution of resveratrol, emodin and their metabolites after intake of Polygonum cuspidatum in rats. Journal of Ethnopharmacology 144:3, pages 671-676.
Crossref
Carolina Emilia Storniolo & Juan Jose Moreno. (2012) Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells. Food Chemistry 134:3, pages 1385-1391.
Crossref
Lan Tang, Juan Zhou, Cai-Hua Yang, Bi-Jun Xia, Ming Hu & Zhong-Qiu Liu. (2012) Systematic Studies of Sulfation and Glucuronidation of 12 Flavonoids in the Mouse Liver S9 Fraction Reveal both Unique and Shared Positional Preferences. Journal of Agricultural and Food Chemistry 60:12, pages 3223-3233.
Crossref
A. Amri, J.C. Chaumeil, S. Sfar & C. Charrueau. (2012) Administration of resveratrol: What formulation solutions to bioavailability limitations?. Journal of Controlled Release 158:2, pages 182-193.
Crossref
M.I. Fernández-Mar, R. Mateos, M.C. García-Parrilla, B. Puertas & E. Cantos-Villar. (2012) Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review. Food Chemistry 130:4, pages 797-813.
Crossref
Leo Nollet & Fidel ToldráMaria Bronze, Catarina Duarte & Ana Matias. 2012. Handbook of Analysis of Active Compounds in Functional Foods. Handbook of Analysis of Active Compounds in Functional Foods 349 378 .
Izet M. Kapetanovic, Miguel Muzzio, Zhihua Huang, Thomas N. Thompson & David L. McCormick. (2010) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemotherapy and Pharmacology 68:3, pages 593-601.
Crossref
Srujana Rayalam, Mary Anne Della‐Fera & Clifton A. Baile. (2011) Synergism between resveratrol and other phytochemicals: Implications for obesity and osteoporosis. Molecular Nutrition & Food Research 55:8, pages 1177-1185.
Crossref
Ernő Tyihák, Zsuzsa Király-Véghely & Ágnes M. Móricz. (2011) Multiple Beneficial Effects of Resveratrol and their Chemical-Biochemical Basis. Natural Product Communications 6:5, pages 1934578X1100600.
Crossref
Mary Ndiaye, Carol Philippe, Hasan Mukhtar & Nihal Ahmad. (2011) The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Archives of Biochemistry and Biophysics 508:2, pages 164-170.
Crossref
David Goldberg & George Soleas. (2011) Wine and Health: A Paradigm for Alcohol and Antioxidants. Journal of Medical Biochemistry 30:2, pages 93-102.
Crossref
Mary Ndiaye, Raj Kumar & Nihal Ahmad. (2011) Resveratrol in cancer management: where are we and where we go from here?. Annals of the New York Academy of Sciences 1215:1, pages 144-149.
Crossref
Juma Hoshino, Eun-Jung Park, Tamara P. Kondratyuk, Laura Marler, John M. Pezzuto, Richard B. van Breemen, Shunyan Mo, Yongchao Li & Mark Cushman. (2010) Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites. Journal of Medicinal Chemistry 53:13, pages 5033-5043.
Crossref
Shirley S Brill, Anna M Furimsky, Mark N Ho, Michael J Furniss, Yi Li, Adam G Green, Carol E Green, Lalitha V Iyer, Wallace W Bradford & Izet M Kapetanovic. (2006) Glucuronidation of trans -resveratrol by human liver and intestinal microsomes and UGT isoforms . Journal of Pharmacy and Pharmacology 58:4, pages 469-479.
Crossref
Mark I Kaldas, U Kristina Walle & Thomas Walle. (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology 55:3, pages 307-312.
Crossref
Alberto A A Bertelli & Dipak K Das. (2009) Grapes, Wines, Resveratrol, and Heart Health. Journal of Cardiovascular Pharmacology 54:6, pages 468-476.
Crossref
Cristina Andres‐Lacueva, Mireia Urpi‐Sarda, Raul Zamora‐Ros & Rosa M. Lamuela‐Raventos. 2009. Plant Phenolics and Human Health. Plant Phenolics and Human Health 265 297 .
Gertz Likhtenshtein. 2009. Stilbenes. Stilbenes 225 260 .
Gertz Likhtenshtein. 2009. Stilbenes. Stilbenes 189 223 .
Lonnie D. Williams, George A. Burdock, James A. Edwards, Mareike Beck & Jochen Bausch. (2009) Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food and Chemical Toxicology 47:9, pages 2170-2182.
Crossref
Raúl F. Guerrero, Maria C. García-Parrilla, Belén Puertas & Emma Cantos-Villar. (2009) Wine, Resveratrol and Health: A Review. Natural Product Communications 4:5, pages 1934578X0900400.
Crossref
Koen van de Wetering, Alexander Burkon, Wouter Feddema, Alice Bot, Hugo de Jonge, Veronika Somoza & Piet Borst. (2009) Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol. Molecular Pharmacology 75:4, pages 876-885.
Crossref
Surajit Das, Hai-Shu Lin, Paul C. Ho & Ka-Yun Ng. (2008) The Impact of Aqueous Solubility and Dose on the Pharmacokinetic Profiles of Resveratrol. Pharmaceutical Research 25:11, pages 2593-2600.
Crossref
Héctor I. Rocha‐González, Mónica Ambriz‐Tututi & Vinicio Granados‐Soto. (2008) Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics 14:3, pages 234-247.
Crossref
Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum & Lalitha V. Iyer. (2008) Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1. Drug Metabolism and Disposition 36:1, pages 129-136.
Crossref
Alberto A.E. Bertelli. (2007) Wine, research and cardiovascular disease: Instructions for use. Atherosclerosis 195:2, pages 242-247.
Crossref
Allan Lançon, Nathalie Hanet, Brigitte Jannin, Dominique Delmas, Jean-Marie Heydel, Gérard Lizard, Marie-Christine Chagnon, Yves Artur & Norbert Latruffe. (2007) Resveratrol in Human Hepatoma HepG2 Cells: Metabolism and Inducibility of Detoxifying Enzymes. Drug Metabolism and Disposition 35:5, pages 699-703.
Crossref
Joseph A. Baur & David A. Sinclair. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery 5:6, pages 493-506.
Crossref
Young Jin Moon, Xiaodong Wang & Marilyn E. Morris. (2006) Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicology in Vitro 20:2, pages 187-210.
Crossref
William Mullen, Christine A. Edwards & Alan Crozier. (2007) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. British Journal of Nutrition 96:01, pages 107.
Crossref
S. Gester, F. Wuest, B. Pawelke, R. Bergmann & J. Pietzsch. (2005) Synthesis and biodistribution of an 18F-labelled resveratrol derivative for small animal positron emission tomography. Amino Acids 29:4, pages 415-428.
Crossref
B. Pawelke. (2005) Metabolite analysis in positron emission tomography studies: examples from food sciences. Amino Acids 29:4, pages 377-388.
Crossref
Alberto Bertelli. 2005. Resveratrol in Health and Disease. Resveratrol in Health and Disease 631 642 .
John Pezzuto. 2005. Resveratrol in Health and Disease. Resveratrol in Health and Disease 233 383 .
Gian Maria Pacifici. 2005. Human Cytosolic Sulfotransferases. Human Cytosolic Sulfotransferases 157 177 .
Catalina Alarcón de la Lastra & Isabel Villegas. (2005) Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Molecular Nutrition & Food Research 49:5, pages 405-430.
Crossref
Elisabeth Wenzel & Veronika Somoza. (2005) Metabolism and bioavailability oftrans-resveratrol. Molecular Nutrition & Food Research 49:5, pages 472-481.
Crossref
Mark F. McCarty. (2005) Potential utility of natural polyphenols for reversing fat-induced insulin resistance. Medical Hypotheses 64:3, pages 628-635.
Crossref
Angéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess & Caroline Teyssier. (2004) METABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVER. Drug Metabolism and Disposition 32:1, pages 58-65.
Crossref
Kaeko Murota & Junji Terao. (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Archives of Biochemistry and Biophysics 417:1, pages 12-17.
Crossref
Chongwoo Yu, Young Geun Shin, Jerome W. Kosmeder, John M. Pezzuto & Richard B. van Breemen. (2003) Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfate. Rapid Communications in Mass Spectrometry 17:4, pages 307-313.
Crossref
David M. Goldberg, Joseph Yan & George J. Soleas. (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry 36:1, pages 79-87.
Crossref
D Goldberg & G Soleas. 2002. Wine. Wine 160 198 .
Miguel Asensi, Ignacio Medina, Angel Ortega, Julian Carretero, M.Carmen Baño, Elena Obrador & Jose M Estrela. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology and Medicine 33:3, pages 387-398.
Crossref
Brian P. Laden & Todd D. Porter. (2001) Resveratrol inhibits human squalene monooxygenase. Nutrition Research 21:5, pages 747-753.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.